LiVeritas Biosciences
LiVeritas Biosciences
  • Home
  • Contact US
    • Home
    • Contact US
  • Home
  • Contact US

LiVeritas Biosciences

LiVeritas BiosciencesLiVeritas BiosciencesLiVeritas Biosciences

 Harnessing Molecular Integrity for Early Informed Decision Making 

LiVeritas Biosciences

LiVeritas BiosciencesLiVeritas BiosciencesLiVeritas Biosciences

 Harnessing Molecular Integrity for Early Informed Decision Making 

Our Culture

We value truth, integrity, respect, and excellence in doing more for others. We believe that patients deserve therapeutic treatments developed under stringent data integrity and quality standards.  


 Truth. Chemistry. Liber. Veritas. LiVeritas.

COnnect with Us

What We Do

Commitment to Truth-telling in Chemistry

 We simplify the complexity of drug development analytical operations and mass spectrometry by delivering high quality data at a lower cost and faster turn-around-time. By harnessing the power of mass spectrometry and digital transformation, we are offering accurate, precise, and timely solutions to drug candidates quality testing that use a fraction of resources.

image704

Drug Development and Testing

Our team has designed and optimized analytical test packages that are effective in rapidly advancing drug candidates in the development pipeline and aid in process development.

image705

Software Solutions

We offer partner-centric software solutions that streamlines mass spectrometry digitization, analytical operations, and drug product knowledge management.

image706

Strategic Partnership

Our team is composed of industry experts with milestone focused biotech startup backgrounds grounded in biopharma core competencies.  

partner with us

Benefits of Solutions

image707

Expert-Guided Insights

Accelerated IND Pathway

Accelerated IND Pathway

Guaranteed team of experts and proprietary know-how to guide every step of the process

Computer analysis

Accelerated IND Pathway

Accelerated IND Pathway

Accelerated IND Pathway

Guaranteed efficiency of streamlined processes and careful selection of IND-enabling tests


Partner with us
image708

Early Intervention

Accelerated IND Pathway

Early Intervention

Guaranteed effectiveness of solutions and information delivery for astute decision making at the speed of the industry

Validation of Core Competencies

There is a growing need for high-quality analytical analysis using mass spectrometry to characterize  biopharmaceuticals to enable the delivery of the best medicines to patients.  Small amounts of variants and modifications in biological products need to be identified and monitored to ensure quality, safety, and efficacy. The team at LiVeritas have the knowledge and experience to deliver characterization data for every stage of drug development with rapid turnaround times to meet accelerated filing deadlines.     


       Amy Hilderbrand, PhD         

       Former  Molecular Assessment Analytical Lead, Genentech PAC        

       Current Affiliation : Frontier Medicines        

       Previous Affiliations : Thermo Fisher Scientific, Roche, GSK, Antheia, Fitbit                                                     

Lieza provided a level of mass spectrometry expertise that allowed us to more effectively develop antibody-drug conjugates (ADCs) from research to manufacturing to nonclinical and clinical development. She was pivotal in characterization/optimization of both small and large molecules, including ADCs.  


      Tae Han, PhD 

      Former Director, Clinical Pharmacology & Pharmacokinetics, Stemcentrx

      Current Affiliation : Co-Founder & COO, Profound Therapeutics

      Previous Affiliations : Merck, Seattle Genetics, Amphivena Therapeutics 


Would you like to hear more about LiVeritas Biosciences?

connect with us

Copyright © 2020 LiVeritas Biosciences, Inc. - All Rights Reserved.